Taiho Pharma's new angiogenesis inhibitor TAS-115 is safe and active in models of cancer April 19, 2011
S*BIO doses first patients in phase II trial of SB-1518 in advanced lymphoid malignancies April 18, 2011
Takeda to participate in phase III trial of Amgen's AMG-479 in metastatic pancreatic cancer April 18, 2011
RSS